In the last decade, there has been a significant increase in medical cases involving brain tumors. Brain tumor is the tenth most common type of tumor, affecting millions of people. However, if it is detected early, the cure rate can increase. Computer vision researchers are working to develop sophisticated techniques for detecting and classifying brain tumors. MRI scans are primarily used for tumor analysis. We proposed an automated system for brain tumor detection and classification using a saliency map and deep learning feature optimization in this paper. The proposed framework was implemented in stages. In the initial phase of the proposed framework, a fusion‐based contrast enhancement technique is proposed. In the following phase, a tumor segmentation technique based on saliency maps is proposed, which is then mapped on original images based on active contour. Following that, a pre‐trained CNN model named EfficientNetB0 is fine‐tuned and trained in two ways: on enhanced images and on tumor localization images. Deep transfer learning is used to train both models, and features are extracted from the average pooling layer. The deep learning features are then fused using an improved fusion approach known as Entropy Serial Fusion. The best features are chosen in the final step using an improved dragonfly optimization algorithm. Finally, the best features are classified using an extreme learning machine (ELM). The experimental process is conducted on three publically available datasets and achieved an improved accuracy of 95.14, 94.89, and 95.94%, respectively. The comparison with several neural nets shows the improvement of proposed framework.
Coronavirus disease 2019 (COVID-19) is a highly contagious disease that has claimed the lives of millions of people worldwide in the last 2 years. Because of the disease's rapid spread, it is critical to diagnose it at an early stage in order to reduce the rate of spread. The images of the lungs are used to diagnose this infection. In the last 2 years, many studies have been introduced to help with the diagnosis of COVID-19 from chest X-Ray images. Because all researchers are looking for a quick method to diagnose this virus, deep learning-based computer controlled techniques are more suitable as a second opinion for radiologists. In this article, we look at the issue of multisource fusion and redundant features. We proposed a CNN-LSTM and improved max value features optimization framework for COVID-19 classification to address these issues. The original images are acquired and the contrast is increased using a combination of filtering algorithms in the proposed architecture. The dataset is then augmented to increase its size, which is then used to train two deep learning networks called Modified EfficientNet B0 and CNN-LSTM. Both networks are built from scratch and extract information from the deep layers. Following the extraction of features, the serial based maximum value fusion technique is proposed to combine the best information of both deep models. However, a few redundant information is also noted; therefore, an improved max value based moth flame optimization algorithm is proposed. Through this algorithm, the best features are selected and finally classified through machine learning classifiers. The experimental process was conducted on three publically available datasets and achieved improved accuracy than the existing techniques. Moreover, the classifiers based comparison is also conducted and the cubic support vector machine gives better accuracy.
COVID-19 detection and classification using chest X-ray images is a current hot research topic based on the important application known as medical image analysis. To halt the spread of COVID-19, it is critical to identify the infection as soon as possible. Due to time constraints and the expertise of radiologists, manually diagnosing this infection from chest X-ray images is a difficult and time-consuming process. Artificial intelligence techniques have had a significant impact on medical image analysis and have also introduced several techniques for COVID-19 diagnosis. Deep learning and explainable AI have shown significant popularity among AL techniques for COVID-19 detection and classification. In this work, we propose a deep learning and explainable AI technique for the diagnosis and classification of COVID-19 using chest X-ray images. Initially, a hybrid contrast enhancement technique is proposed and applied to the original images that are later utilized for the training of two modified deep learning models. The deep transfer learning concept is selected for the training of pretrained modified models that are later employed for feature extraction. Features of both deep models are fused using improved canonical correlation analysis that is further optimized using a hybrid algorithm named Whale-Elephant Herding. Through this algorithm, the best features are selected and classified using an extreme learning machine (ELM). Moreover, the modified deep models are utilized for Grad-CAM visualization. The experimental process was conducted on three publicly available datasets and achieved accuracies of 99.1, 98.2, and 96.7%, respectively. Moreover, the ablation study was performed and showed that the proposed accuracy is better than the other methods.
With the quick evolution of medical technology, the era of big data in medicine is quickly approaching. The analysis and mining of these data significantly influence the prediction, monitoring, diagnosis, and treatment of tumor disorders. Since it has a wide range of traits, a low survival rate, and an aggressive nature, brain tumor is regarded as the deadliest and most devastating disease. Misdiagnosed brain tumors lead to inadequate medical treatment, reducing the patient's life chances. Brain tumor detection is highly challenging due to the capacity to distinguish between aberrant and normal tissues. Effective therapy and long-term survival are made possible for the patient by a correct diagnosis. Despite extensive research, there are still certain limitations in detecting brain tumors because of the unusual distribution pattern of the lesions. Finding a region with a small number of lesions can be difficult because small areas tend to look healthy. It directly reduces the classification accuracy, and extracting and choosing informative features is challenging. A significant role is played by automatically classifying early-stage brain tumors utilizing deep and machine learning approaches. This paper proposes a hybrid deep learning model Convolutional Neural Network-Long Short Term Memory (CNN-LSTM) for classifying and predicting brain tumors through Magnetic Resonance Images (MRI). We experiment on an MRI brain image dataset. First, the data is preprocessed efficiently, and then, the Convolutional Neural Network (CNN) is applied to extract the significant features from images. The proposed model predicts the brain tumor with a significant classification accuracy of 99.1%, a precision of 98.8%, recall of 98.9%, and F1-measure of 99.0%.
One of the most challenging tasks for clinicians is detecting symptoms of cardiovascular disease as earlier as possible. Many individuals worldwide die each year from cardiovascular disease. Since heart disease is a major concern, it must be dealt with timely. Multiple variables affecting health, such as excessive blood pressure, elevated cholesterol, an irregular pulse rate, and many more, make it challenging to diagnose cardiac disease. Thus, artificial intelligence can be useful in identifying and treating diseases early on. This paper proposes an ensemble-based approach that uses machine learning (ML) and deep learning (DL) models to predict a person’s likelihood of developing cardiovascular disease. We employ six classification algorithms to predict cardiovascular disease. Models are trained using a publicly available dataset of cardiovascular disease cases. We use random forest (RF) to extract important cardiovascular disease features. The experiment results demonstrate that the ML ensemble model achieves the best disease prediction accuracy of 88.70%.
Smart monitoring and assisted living systems for cognitive health assessment play a central role in assessment of individuals’ health conditions. Autistic children suffer from some difficulties including social skills, repetitive behaviors, speech and nonverbal communication, and accommodating to the environment around them. Thus, dealing with autistic children is a serious public health problem as it is hard to determine what they feel with a lack of emotional cognitive ability. Currently, no medical treatments have been shown to cure autistic children, with most of the social assistive research to date focusing on Autism Spectrum Disorder (ASD) without suggesting a real treatment. In this paper, we focus on improving cognitive ability and daily living skills and maximizing the ability of the autistic child to function and participate positively in the community. Through utilizing intelligent systems based Artificial Intelligence (AI) and Internet of Things (IoT) technologies, we facilitate the process of adaptation to the world around the autistic children. To this end, we propose an AI-enabled IoT system embodied in a sensor for measuring the heart rate to predict the state of the child and then sending the state to the guardian with feeling and expected behavior of the child via a mobile application. Further, the system can provide a new virtual environment to help the child to be capable of improving eye contact with other people. This way is represented in pictures of these persons in 3D models that break this child’s fear barrier. The system follows strategies that have focused on social communication skill development particularly at young ages to be more interactive with others.
With the prevalence of cognitive diseases, the health industry is facing newer challenges since cognitive health deteriorates gradually over time, and clear signs and symptoms appear when it is too late. Smart homes and the IoT (Internet of Things) have given hope to the health industry to monitor and manage the elderly and the less-abled in the comfort of their homes. Smart homes have been most influential in detecting and managing cognitive diseases like dementia. They can give a comprehensive view of the ADL (Activities of Daily Living) of dementia patients. ADLs are categorized as activities of daily life and complex interwoven activities. First signs of cognitive decline appear when a cognitively impaired individual tries to perform complex activities involving planning, analyzing, calculating, and decision making. Therefore, we analyze individuals’ performance while performing complex activities as opposed to Simple ADL. Artificial Intelligence has been one of health-care’s most promising techniques for prediction and diagnosis. When applied to ADL data, machine learning and deep learning algorithms can conveniently and accurately analyze activity patterns and predict the first signs of cognitive decline. Our proposed work uses machine and deep learning classifiers to classify dementia and healthy individuals by analyzing complex interwoven activity data. We use the subset of the CASAS (Centre of Advanced Studies in Adaptive Systems) dataset for eight complex activities performed by 179 individuals in a smart home setting. decision tree, Naive Bayes, support vector, multilayer perceptron classifiers, and deep neural networks have been used for classification. Their results and performances are compared to determine the best classifier. It is observed that deep neural networks and multilayer perceptron show the best results for classifying dementia vs. healthy individuals when evaluating their complex interwoven activities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.